Home/Filings/4/0001209191-09-048501
4//SEC Filing

GALEN PARTNERS IV LP 4

Accession 0001209191-09-048501

CIK 0001254419other

Filed

Oct 12, 8:00 PM ET

Accepted

Oct 13, 7:13 PM ET

Size

23.7 KB

Accession

0001209191-09-048501

Insider Transaction Report

Form 4
Period: 2009-10-08
CLAUDIUS LLC
10% Owner
Transactions
  • Other

    Common Stock

    2009-10-0945,1115,924,244 total(indirect: See footnotes)
  • Sale

    Common Stock

    2009-10-08$22.06/sh15,199$335,2905,969,355 total(indirect: See footnotes)
Transactions
  • Other

    Common Stock

    2009-10-0945,1115,924,244 total(indirect: See footnotes)
  • Sale

    Common Stock

    2009-10-08$22.06/sh15,199$335,2905,969,355 total(indirect: See footnotes)
Transactions
  • Other

    Common Stock

    2009-10-0945,1115,924,244 total(indirect: See footnotes)
  • Sale

    Common Stock

    2009-10-08$22.06/sh15,199$335,2905,969,355 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2009-10-08$22.06/sh15,199$335,2905,969,355 total(indirect: See footnotes)
  • Other

    Common Stock

    2009-10-0945,1115,924,244 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2009-10-08$22.06/sh15,199$335,2905,969,355 total(indirect: See footnotes)
  • Other

    Common Stock

    2009-10-0945,1115,924,244 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2009-10-08$22.06/sh15,199$335,2905,969,355 total(indirect: See footnotes)
  • Other

    Common Stock

    2009-10-0945,1115,924,244 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2009-10-08$22.06/sh15,199$335,2905,969,355 total(indirect: See footnotes)
  • Other

    Common Stock

    2009-10-0945,1115,924,244 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2009-10-08$22.06/sh15,199$335,2905,969,355 total(indirect: See footnotes)
  • Other

    Common Stock

    2009-10-0945,1115,924,244 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2009-10-08$22.06/sh15,199$335,2905,969,355 total(indirect: See footnotes)
  • Other

    Common Stock

    2009-10-0945,1115,924,244 total(indirect: See footnotes)
Footnotes (7)
  • [F1]The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Funds on September 1, 2009.
  • [F2]The shares were sold as follows: 2,674 by Galen Partners IV, L.P. ("Galen IV"), 211 shares by Galen Partners International IV, L.P. ("Galen International IV"), 4 shares by Galen Employee Fund IV, L.P. ("Employee Fund IV"), 11,252 by Galen Partners III, L.P. ("Galen III"), 1,020 by Galen Partners International III, L.P. ("Galen International III") and 38 shares by Galen Employee Fund III, L.P. ("Employee Fund III" and, collectively with Galen IV, Galen International IV, Employee Fund IV, Galen III, Galen International III, the "Funds").
  • [F3]The shares are held as follows: 1,041,446 by Galen IV, 82,728 by Galen International IV, 1,453 by Employee Fund IV, 4,382,702 by Galen III, 397,189 by Galen International III, 18,726 by Employee Fund III and 45,111 by Galen Investment Advisory Group, L.L.C. ("Galen Investment"). Claudius IV, L.L.C. serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds.
  • [F4]Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.
  • [F5]Represents a pro rata distribution of 45,111 shares by Galen Investment to its members.
  • [F6]The shares are held as follows: 1,041,446 by Galen IV, 82,728 by Galen International IV, 1,453 by Employee Fund IV, 4,382,702 by Galen III, 397,189 by Galen International III, 18,726 by Employee Fund III. Claudius IV, L.L.C. serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds.
  • [F7]Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.

Issuer

MEDASSETS INC

CIK 0001254419

Entity typeother

Related Parties

1
  • filerCIK 0001203341

Filing Metadata

Form type
4
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 7:13 PM ET
Size
23.7 KB